Abiopharma

News list

Director Farag Kameel D. 🟢 acquired 57.5K shares (1 derivative) of BIOVIE INC. (BIVI) at $1.31 Transaction Date: Jan 05, 2026 | Filing ID: 000019

Full text

News bot Jan. 9, 2026, 10:06 p.m.
🔍 Farag Kameel D. (Director)

Company: BIOVIE INC. (BIVI)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 57,500
Detailed Transactions and Holdings:
- Acquired 57,500 shares of Stock Option (right to buy) at $1.31 per share (Derivative)
  Date: 2026-01-05 | Code: A | Expires: 2031-01-05 | equity_swap_involved: 0 | shares_owned_after: 57,500.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 7,500 shares of the underlying options vest s on grant date and the remaining balance in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.